Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Recent News
Dr. Genovese was recently a Project Leader at the San Raffaele Telethon Institute for Gene Therapy, having completed his post-doctoral fellowship in the laboratory of Molecular and Cell Biology of Gene Transfer with Professor Luigi Naldini in Italy. His current resarch focuses on gene-engineering technologies with a focus on hematopoietic stem cells and T cells. His future aim is to broaden his studies on pre-clinical development and to advance genetic engineering strategies with the aim to develop new treatment for human diseases, including cancer. Pietro will be joining the Gene Therapy Program in Pediatric Hematology/Oncology and the Program for Gene Therapy of Rare Diseases in the Department of Pediatrics (DOP). He has already had an impressively productive post-doctoral career with multiple publications, successful grant applications and patents filed.
Dana-Farber Cancer Institute450 Brookline AvenueBoston, MA 02215Get Directions